To determine whether AXL affected the sensitivity of high-AXL-expressing EGFR-mutated NSCLC cells to osimertinib in vivo, we used PC-9 cells in which AXL expression was continuously knocked down by transfection of short hairpin RNAs (shRNAs). Here, EGFR is linked to non-small cell lung carcinoma.